跳至主要内容
临床试验/KCT0002264
KCT0002264招募中未知

Identification of predictive biomarkers for treatment outcome in patients with advanced hepatocellular carcinoma

Yonsei University Health System, Severance Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • ? unresectable primary liver cancer
  • ? Age 20 years old or older
  • ? Whole body performance (ECOG) 0-2
  • ? Child-Pugh score is B or more
  • ? Minimum volume of normal liver without tumor invasion> 1000cm3
  • ? Minimum distance between target and organ at risk (eg duodenum, stomach) = 0.5cm
  • ? Adequate *LFT (*AST / *ALT <5 x upper limit of normal, total bilirubin> <3 mg / dl, albumin> 2.5 g / dL, normal *PT / *PTT)
  • ? Adequate renal function (creatinine <1.8 mg / dl or *Ccr> 50 ml / min)
  • ? *BM reserve (*ANC =1500 / mm3, *PLT =50000 / mm3, *Hb> 9 g / dl)
  • ? lesion that can be measured or evaluated on CT
  • ? Those who are pregnant and who agree to contraception
  • ? The person who can read and understand the research agreement and sign the study agreement.
  • *LFT(liver function test)
  • *AST(aspartate aminotransferase)
  • *ALT(alanine Transaminase)
  • *PT(Prothrombin Time)
  • *PTT(Partial Thromboplastin Time)
  • *BM(Bone Marrow)
  • *ANC(Absolute Neutrophil Count)
  • *PLT(Platelet count)
  • *Hb(Hemoglobin)
  • *Ccr(Creatinine clearance)

排除标准

  • ? Those who can not perform respiratory training for treatment design
  • ? Patients with a history of previous abdominal radiation therapy
  • ? Those who can not receive consent before treatment
  • ? Those who do not agree to contraception as a pregnant patient

研究者

相似试验

Identification of predictive biomarkers for... | 临床试验